[HTML][HTML] Risk and protective factors for COVID-19 morbidity, severity, and mortality
J Zhang, X Dong, G Liu, Y Gao - Clinical reviews in allergy & immunology, 2023 - Springer
The outbreak of the coronavirus disease 2019 (COVID-19), caused by the novel severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has become an evolving global …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has become an evolving global …
[HTML][HTML] Stem cell-based therapy for human diseases
DM Hoang, PT Pham, TQ Bach, ATL Ngo… - Signal transduction and …, 2022 - nature.com
Recent advancements in stem cell technology open a new door for patients suffering from
diseases and disorders that have yet to be treated. Stem cell-based therapy, including …
diseases and disorders that have yet to be treated. Stem cell-based therapy, including …
[HTML][HTML] Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 …
Early increase of soluble urokinase plasminogen activator receptor (suPAR) serum levels is
indicative of increased risk of progression of coronavirus disease 2019 (COVID-19) to …
indicative of increased risk of progression of coronavirus disease 2019 (COVID-19) to …
Demographic risk factors for COVID-19 infection, severity, ICU admission and death: a meta-analysis of 59 studies
Objective We aimed to describe the associations of age and sex with the risk of COVID-19 in
different severity stages ranging from infection to death. Design Systematic review and meta …
different severity stages ranging from infection to death. Design Systematic review and meta …
[HTML][HTML] Aging, immunity, and COVID-19: how age influences the host immune response to coronavirus infections?
V Bajaj, N Gadi, AP Spihlman, SC Wu, CH Choi… - Frontiers in …, 2021 - frontiersin.org
The novel coronavirus severe acute respiratory syndrome coronavirus 2 causing the
Coronavirus disease (COVID-19) pandemic has ravaged the world with over 72 million total …
Coronavirus disease (COVID-19) pandemic has ravaged the world with over 72 million total …
[HTML][HTML] From SARS and MERS to COVID-19: a brief summary and comparison of severe acute respiratory infections caused by three highly pathogenic human …
Z Zhu, X Lian, X Su, W Wu, GA Marraro, Y Zeng - Respiratory research, 2020 - Springer
Within two decades, there have emerged three highly pathogenic and deadly human
coronaviruses, namely SARS-CoV, MERS-CoV and SARS-CoV-2. The economic burden …
coronaviruses, namely SARS-CoV, MERS-CoV and SARS-CoV-2. The economic burden …
[HTML][HTML] Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors
M Ripa, L Galli, A Poli, C Oltolini, V Spagnuolo… - Clinical Microbiology …, 2021 - Elsevier
Objectives The aim of our study was to describe the incidence and predictive factors of
secondary infections in patients with coronavirus disease 2019 (COVID-19). Methods This …
secondary infections in patients with coronavirus disease 2019 (COVID-19). Methods This …
[HTML][HTML] Corticosteroid use in COVID-19 patients: a systematic review and meta-analysis on clinical outcomes
J Van Paassen, JS Vos, EM Hoekstra, KMI Neumann… - Critical Care, 2020 - Springer
Background In the current SARS-CoV-2 pandemic, there has been worldwide debate on the
use of corticosteroids in COVID-19. In the recent RECOVERY trial, evaluating the effect of …
use of corticosteroids in COVID-19. In the recent RECOVERY trial, evaluating the effect of …
[HTML][HTML] SARS-CoV-2 engages inflammasome and pyroptosis in human primary monocytes
AC Ferreira, VC Soares… - Cell death …, 2021 - nature.com
Infection by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been
associated with leukopenia and uncontrolled inflammatory response in critically ill patients …
associated with leukopenia and uncontrolled inflammatory response in critically ill patients …
The spectrum of COVID-19–associated dermatologic manifestations: An international registry of 716 patients from 31 countries
EE Freeman, DE McMahon, JB Lipoff… - Journal of the American …, 2020 - Elsevier
Background Coronavirus disease 2019 (COVID-19) has associated cutaneous
manifestations. Objective To characterize the diversity of cutaneous manifestations of COVID …
manifestations. Objective To characterize the diversity of cutaneous manifestations of COVID …